Have your own idea? Try our Stock Screener
Japanese (NIKKEI) Clinical Research and Equipment Industry Analysis
UpdatedMar 28, 2026
DataAggregated Company Financials
Companies14
- 7D-1.3%
- 3M-7.5%
- 1Y-7.4%
- YTDn/a
Over the last 7 days, the Clinical Research and Equipment industry has dropped 1.3%, driven by a pullback from Shin Nippon Biomedical Laboratories of 2.8%. In contrast, Carna Biosciences has gained 14%. Overall the industry is down 7.4% in 12 months. As for the next few years, earnings are expected to grow by 14% per annum.
Industry Valuation and Performance
Has the Japanese Clinical Research and Equipment Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sat, 28 Mar 2026 | JP¥141.0b | JP¥63.3b | -JP¥864,966,000.00 | 21.5x | -163x | 2.2x |
| Mon, 23 Feb 2026 | JP¥156.6b | JP¥63.2b | -JP¥944,048,000.00 | 23.2x | -165.9x | 2.5x |
| Wed, 21 Jan 2026 | JP¥154.3b | JP¥66.9b | JP¥72.2m | 23.7x | 2137.1x | 2.3x |
| Fri, 19 Dec 2025 | JP¥151.8b | JP¥66.9b | JP¥72.2m | 20.3x | 2102.4x | 2.3x |
| Sun, 16 Nov 2025 | JP¥138.5b | JP¥67.5b | JP¥834.9m | 17.7x | 165.9x | 2.1x |
| Tue, 14 Oct 2025 | JP¥142.2b | JP¥66.5b | JP¥1.5b | 16.5x | 97.5x | 2.1x |
| Thu, 11 Sep 2025 | JP¥148.3b | JP¥66.5b | JP¥1.5b | 16.7x | 101.7x | 2.2x |
| Sat, 09 Aug 2025 | JP¥141.3b | JP¥66.9b | JP¥1.4b | 16.6x | 100.4x | 2.1x |
| Mon, 07 Jul 2025 | JP¥140.5b | JP¥66.0b | JP¥1.1b | 16.1x | 124.4x | 2.1x |
| Wed, 04 Jun 2025 | JP¥138.8b | JP¥66.0b | JP¥1.1b | 17.3x | 122.5x | 2.1x |
| Fri, 02 May 2025 | JP¥144.7b | JP¥64.2b | JP¥1.5b | 14.9x | 94.1x | 2.3x |
| Sun, 30 Mar 2025 | JP¥157.4b | JP¥64.8b | JP¥927.4m | 15.4x | 169.7x | 2.4x |
| Tue, 25 Feb 2025 | JP¥165.2b | JP¥65.1b | JP¥1.1b | 15.8x | 148x | 2.5x |
| Thu, 23 Jan 2025 | JP¥160.4b | JP¥62.0b | JP¥440.7m | 17.9x | 363.9x | 2.6x |
| Sat, 21 Dec 2024 | JP¥158.3b | JP¥62.0b | JP¥440.7m | 17.1x | 359.1x | 2.6x |
| Mon, 18 Nov 2024 | JP¥153.8b | JP¥62.6b | JP¥1.3b | 19.9x | 115.3x | 2.5x |
| Wed, 16 Oct 2024 | JP¥151.8b | JP¥61.5b | JP¥1.8b | 20.8x | 82.5x | 2.5x |
| Fri, 13 Sep 2024 | JP¥157.5b | JP¥61.6b | JP¥2.1b | 18.3x | 76.2x | 2.6x |
| Sun, 11 Aug 2024 | JP¥140.9b | JP¥61.5b | JP¥2.0b | 19x | 69.6x | 2.3x |
| Tue, 09 Jul 2024 | JP¥164.2b | JP¥61.8b | JP¥3.2b | 25.8x | 50.7x | 2.7x |
| Thu, 06 Jun 2024 | JP¥162.5b | JP¥61.8b | JP¥3.3b | 25.2x | 49.6x | 2.6x |
| Sat, 04 May 2024 | JP¥182.6b | JP¥62.3b | JP¥3.3b | 14x | 55.5x | 2.9x |
| Mon, 01 Apr 2024 | JP¥234.9b | JP¥155.4b | JP¥8.6b | 14x | 27.3x | 1.5x |
| Wed, 28 Feb 2024 | JP¥237.5b | JP¥155.3b | JP¥8.7b | 14.6x | 27.3x | 1.5x |
| Fri, 26 Jan 2024 | JP¥228.7b | JP¥167.1b | JP¥8.5b | 15.4x | 26.9x | 1.4x |
| Sun, 24 Dec 2023 | JP¥222.2b | JP¥167.1b | JP¥8.5b | 14.8x | 26.1x | 1.3x |
| Tue, 21 Nov 2023 | JP¥236.0b | JP¥167.4b | JP¥8.7b | 15.1x | 27.2x | 1.4x |
| Thu, 19 Oct 2023 | JP¥230.6b | JP¥179.3b | JP¥12.8b | 14.3x | 18.1x | 1.3x |
| Sat, 16 Sep 2023 | JP¥257.5b | JP¥179.3b | JP¥12.8b | 15.7x | 20.1x | 1.4x |
| Mon, 14 Aug 2023 | JP¥272.4b | JP¥180.0b | JP¥13.7b | 17.6x | 19.8x | 1.5x |
| Wed, 12 Jul 2023 | JP¥279.5b | JP¥178.5b | JP¥16.2b | 16.8x | 17.2x | 1.6x |
| Fri, 09 Jun 2023 | JP¥282.6b | JP¥178.3b | JP¥16.2b | 16.9x | 17.4x | 1.6x |
| Sun, 07 May 2023 | JP¥288.7b | JP¥174.9b | JP¥16.5b | 16.6x | 17.5x | 1.7x |
| Tue, 04 Apr 2023 | JP¥310.5b | JP¥171.9b | JP¥13.3b | 17.2x | 23.4x | 1.8x |
Price to Earnings Ratio
23.4x
Current Industry PE
- Investors are relatively neutral on the Japanese Life Sciences Tools and Services industry at the moment, indicating that they anticipate long term growth rates to remain steady.
- The industry is trading close to its 3-year average PS ratio of 2.1x.
Past Earnings Growth
- Total earnings for the Life Sciences Tools and Services industry have declined over the last three years, with the industry now making a loss overall.
- Revenues have also declined 28% per year, which is driving profits down.
Industry Comparison
How does Japanese Clinical Research and Equipment compare with similar industries?
| JP Market | 0.86% | |
| Healthcare | 2.45% | |
| Life Sciences | -1.31% | |
| Clinical Research and Equipment | -1.31% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 4572 Carna Biosciences | JP¥401.00 | 14.2% +JP¥959.3m | 34.1% | PS13.3x | |
| 6190 PhoenixBio | JP¥475.00 | 4.4% +JP¥81.4m | 25.3% | PS1.2x | |
| 4570 Immuno-Biological Laboratories | JP¥1.41k | 0.5% +JP¥65.2m | 183.3% | PE35.9x |